Q32 Bio Inc.QTTB
Price (close)
$9.22
Market cap
$274.5M
P/E
8.1x
Revenue (TTM)
$53.7M
Net income
$33.8M
Dividend yield
—
1-year total return
390.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Q32 Bio Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $34.0M | $3.2M | -$6.7M | $0 | $53.7M |
| Net income | -$128.7M | -$95.8M | -$5.0M | -$53.7M | -$47.7M | $29.8M |
| Free cash flow | -$98.1M | -$112.1M | -$114.9M | -$18.7M | -$67.8M | -$33.5M |
More on QTTB.
- Q32 Bio Inc. summary
- Q32 Bio Inc. financial statements
- Q32 Bio Inc. key metrics
- Q32 Bio Inc. health scores and style box
- Q32 Bio Inc. earnings
- Q32 Bio Inc. dividends
- Q32 Bio Inc. valuation
- Q32 Bio Inc. ownership and insiders
- Q32 Bio Inc. peers
Figures from Q32 Bio Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.